Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix

被引：6

作者：

Ong, Shawn Y. ^{[1
]}

Taverna, Josephine ^{[2
]}

Jokerst, Clint ^{[3
]}

Enzler, Thomas ^{[4
]}

Hammode, Emad ^{[4
]}

Rogowitz, Elisa ^{[5
]}

Green, Myke R. ^{[6
]}

Babiker, Hani ^{[2
,7
]}

机构：

[1] Univ Arizona, Coll Med, Tucson, AZ 85724 USA

[2] Univ Arizona, Ctr Canc, 1501 N Campbell Ave, Tucson, AZ 85724 USA

[3] Univ Arizona, Coll Med, Dept Radiol, Tucson, AZ 85724 USA

[4] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85724 USA

[5] Scripps Hlth, Dept Med, La Jolla, CA 92037 USA

[6] Univ Arizona, Med Ctr, Dept Pharm Serv, Tucson, AZ 85724 USA

[7] HonorHlth Res Inst, Virginia G Piper Canc Ctr Clin Trials, Scottsdale, AZ 85258 USA

来源：

CASE REPORTS IN ONCOLOGICAL MEDICINE | 2015年 / 2015卷

关键词：

D O I：

10.1155/2015/212543

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute life-threatening variant of DIC in patients with prostate cancer. Patients present with coagulopathy, hypofibrinogenemia, and systemic bleeding. We describe a case of DIC XFL caused by prostate cancer (PC) successfully treated with a single injection of degarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist. This led to prompt control of the patient's coagulopathy within ten days of treatment. Our case highlights features of this rare and devastating hemorrhagic complication of PC along with a fast-acting and effective therapeutic drug option.

引用

页数：6

共 50 条

[41] EVIDENCE THAT THROMBIN MEDIATES SECONDARY FIBRINOLYSIS IN DISSEMINATED INTRAVASCULAR COAGULATION
TAYLOR, F
CHANG, A
HOOGENDORNE, H
MARAGANORE, JM
THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1238 - 1238
[42] DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH NEOPLASIA
SLAPPENDEL, RJ
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1988, 18 (01) : 271 - 273
[43] Machine learning models can predict cancer-associated disseminated intravascular coagulation in critically ill colorectal cancer patients
Qin, Li
Mao, Jieling
Gao, Min
Xie, Jingwen
Liang, Zhikun
Li, Xiaoyan
FRONTIERS IN PHARMACOLOGY, 2024, 15
[44] Disseminated intravascular coagulation associated with intratumoral hemorrhage of ovarian cancer
Matsushita, H
Kurabayashi, T
Tomita, M
Yamamoto, Y
Aoki, Y
Tanaka, K
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2001, 51 (04) : 274 - 276
[45] Disseminated intravascular coagulation associated with pancytopenia
Jennane, Selim
Mahtat, El Mehdi
Doghmi, Kamal
Mikdame, Mohammed
PRESSE MEDICALE, 2013, 42 (11): : 1547 - 1549
[46] DISSEMINATED INTRAVASCULAR COAGULATION IN NEONATE TREATED WITH HEPARIN
MARKARIAN, M
COHEN, RJ
MILBAUER, B
JOURNAL OF PEDIATRICS, 1971, 78 (01): : 74 - +
[47] Thrombin-activatable fibrinolysis inhibitor and organ dysfunction in disseminated intravascular coagulation associated with sepsis
M Hayakawa
A Sawamura
M Sugano
S Uegaki
N Kubota
S Gando
S Jesmin
Critical Care, 15 (Suppl 3):
[48] FIBRINOLYSIS AND INTRAVASCULAR COAGULATION SEPARATE OR ASSOCIATED MECHANISMS
IATRIDIS, SG
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1966, S : 53 - &
[49] Disseminated intravascular coagulation with excessive fibrinolysis in a patient with metastatic endometrial carcinoma - Influence of various treatments on the coagulopathy (a case report)
Weltermann, A
Mitterbauer, GJ
Mitterbauer, M
Hattey, E
Speiser, W
Gisslinger, H
Knobl, P
Eichinger, S
WIENER KLINISCHE WOCHENSCHRIFT, 1998, 110 (02) : 53 - 57
[50] Disseminated intravascular coagulation in cancer patients
Levi, Marcel
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (01) : 129 - 136

← 1 2 3 4 5 →